Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Novogen completes private placement

    Novogen Ltd. (ASX:NRT; NASDAQ:NVGN), Hornsby, Australia Business: Cancer, Neurology Date completed: 2015-04-29 Type: Private placement Raised: A$15.5 million ($12.1 million) Shares: 51.8 million Price: A$0.30 Shares …

    Published on 5/4/2015
  • OncoGenex completes private placement of units

    OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI), Bothell, Wash. Business: Cancer Date completed: 2015-04-30 Type: Private placement of units Raised: $2 million Units: 956,938 Price: $2.09 (unit) Shares after offering: 23.6…

    Published on 5/4/2015
  • Pamlico completes venture financing

    Pamlico BioPharma Inc., Oklahoma City, Okla. Business: Antibodies, Infectious Date completed: 2015-04-29 Type: Venture financing Raised: $2.2 million Investors: Accele Venture Partners L.P.; Oklahoma Seed Capital Fund

    Published on 5/4/2015
  • Paratek completes follow-on

    Paratek Pharmaceuticals Inc. (NASDAQ:PRTK), Boston, Mass. Business: Infectious, Dermatology, Neurology Date completed: 2015-04-29 Type: Follow-on Raised: $70.1 million Shares: 2.9 million Price: $24.50 Shares after …

    Published on 5/4/2015
  • PEP-Therapy completes venture financing

    PEP-Therapy S.A.S., Evry, France Business: Cancer Date completed: 2015-04-27 Type: Venture financing Raised: EUR1.3 million ($1.4 million) Investors: Seventure Partners; private investor

    Published on 5/4/2015
  • Protea Biosciences completes private placement of convertible preferred stock and warrants

    Protea Biosciences Group Inc. (OTCQB:PRGB), Morgantown, W.Va. Business: Diagnostic, Supply/Service Date completed: 2015-04-27 Type: Private placement of convertible preferred stock and warrants Raised: $7.4 million …

    Published on 5/4/2015
  • Rapid Micro Biosystems completes venture financing

    Rapid Micro Biosystems Inc., Lowell, Mass. Business: Supply/Service Date completed: 2015-04-29 Type: Venture financing Raised: $25 million Investors: Shenzhen Hepalink Pharmaceutical Co. Ltd.; Richard King Mellon …

    Published on 5/4/2015
  • Theraclone completes venture financing

    Theraclone Sciences Inc., Seattle, Wash. Business: Infectious, Inflammation Date completed: 2015-04-30 Type: Venture financing Raised: $3.1 million Investors: Wellcome Trust; existing investors Note: Theraclone raised $…

    Published on 5/4/2015
  • Viking Therapeutics completes IPO

    Viking Therapeutics Inc. (NASDAQ:VKTX), San Diego, Calif. Business: Endocrine/Metabolic, Musculoskeletal, Hematology Date completed: 2015-04-29 Type: IPO Raised: $24 million Shares: 3 million Price: $8 Shares after …

    Published on 5/4/2015
  • CRISPR Therapeutics financial update

    CRISPR Therapeutics AG, Basel, Switzerland Business: Gene/Cell therapy Date announced: 2015-04-29 Note: CRISPR raised $35 million in a final close of a series A round, bringing the total raised to $60 million. New …

    Published on 5/4/2015
  • Lipocine financial update

    Lipocine Inc. (NASDAQ:LPCN), Salt Lake City, Utah Business: Drug delivery Date announced: 2015-04-29 Note: Lipocine raised $4.5 million through the sale of 697,500 shares at $6.50 to cover the overallotment from its …

    Published on 5/4/2015
  • Affimed proposes follow-on

    Affimed N.V. (NASDAQ:AFMD), Heidelberg, Germany Business: Cancer, Inflammation, Antibodies Date announced: 2015-04-27 Type: Follow-on To be raised: Up to $40.3 million Shares: TBD Price prior: $11.72 Underwriters: …

    Published on 5/4/2015
  • Karo Bio proposes rights offering

    Karo Bio AB (SSE:KARO), Stockholm, Sweden Business: Endocrine/Metabolic Date announced: 2015-04-29 Type: Rights offering To be raised: Up to SEK229.9 million ($26.6 million) Shares: 229.9 million Price: SEK1 Shares …

    Published on 5/4/2015
  • Novogen proposes rights offering

    Novogen Ltd. (ASX:NRT; NASDAQ:NVGN), Hornsby, Australia Business: Cancer, Neurology Date announced: 2015-04-21 Type: Rights offering To be raised: Up to A$16.9 million ($13.2 million) Shares: 56.4 million Price: A$0.30 …

    Published on 5/4/2015
  • Syngene proposes IPO

    Syngene International Ltd., Bangalore, India Business: Supply/Service Date announced: 2015-04-22 Type: IPO To be raised: TBD Shares: 22 million Price: TBD Underwriters: Axis Financial Group; Credit Suisse; Jefferies …

    Published on 5/4/2015
  • Blueprint Medicines amends IPO

    Blueprint Medicines Corp., Cambridge, Mass. Business: Cancer Date announced: 2015-04-21 Type: IPO To be raised: Up to $122.2 million Shares: 7.2 million Price: $15-$17 Underwriters: Goldman Sachs; Cowen; JMP Securities;…

    Published on 4/27/2015
  • CoLucid amends IPO

    CoLucid Pharmaceuticals Inc., Durham, N.C. Business: Neurology Date announced: 2015-04-20 Type: IPO To be raised: Up to $80.4 million Shares: 5.4 million Price: $13-$15 Underwriters: Piper Jaffray; Stifel, Nicolaus; …

    Published on 4/27/2015
  • DelMar Pharmaceuticals Inc amends follow-on

    DelMar Pharmaceuticals Inc. (OTCQX:DMPI), Vancouver, B.C. Business: Cancer Date announced: 2015-04-21 Type: Follow-on To be raised: Up to $10 million Shares: TBD Price prior: $0.71 Underwriters: Maxim Group; Roth …

    Published on 4/27/2015
  • Jaguar Animal Health amends IPO

    Jaguar Animal Health Inc., San Francisco, Calif. Business: Veterinary Date announced: 2015-03-20 Type: IPO To be raised: Up to $22.1 million Shares: 3.2 million Price: $7 Underwriters: Aegis Capital; CRT Capital; Feltl …

    Published on 4/27/2015
  • MultiVir amends IPO

    MultiVir Inc., Houston, Texas Business: Cancer Date announced: 2015-04-23 Type: IPO To be raised: Up to $64.4 million Shares: 4.6 million Price: $12-$14 Underwriters: RBC Capital Markets; Nomura; Cantor Fitzgerald; …

    Published on 4/27/2015
  • Aduro Biotech Inc completes private placement

    Aduro Biotech Inc. (NASDAQ:ADRO), Berkeley, Calif. Business: Cancer Date completed: 2015-04-20 Type: Private placement Raised: $25 million Shares: 1.5 million Price: $17 Shares after offering: 60 million Investor: …

    Published on 4/27/2015
  • Ariste Medical completes venture financing

    Ariste Medical Inc., Memphis, Tenn. Business: Drug delivery Date completed: 2015-04-21 Type: Venture financing Raised: $4.6 million Investor: Not disclosed

    Published on 4/27/2015
  • Biocartis Group N.V completes IPO

    Biocartis Group N.V. (Euronext:BCART), Mechelen, Belgium Business: Diagnostic Date completed: 2015-04-23 Type: IPO Raised: EUR100 million ($107.8 million) Shares: 8.7 million Price: EUR11.50 Shares after offering: 39.1 …

    Published on 4/27/2015
  • Dimension Therapeutics completes venture financing

    Dimension Therapeutics Inc., Cambridge, Mass. Business: Gene/Cell therapy, Hematology Date completed: 2015-04-21 Type: Venture financing Raised: $65 million Investors: New Leaf Venture Partners; Jennison Associates; …

    Published on 4/27/2015
  • DNAnexus completes venture financing

    DNAnexus Inc., Mountain View, Calif. Business: Bioinformatics, Genomics Date completed: 2015-04-22 Type: Venture financing Raised: $15 million Investor: WuXi PharmaTech Inc.

    Published on 4/27/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993